Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -52.96% is 32% above its 5-year average of -77.69%, near the high end of its 5-year range (-145.28%–-39.80%).
3.90% above its 12-month average of -55.11%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -39.80%.
OPERATING MARGIN
-52.96%
OPERATING MARGIN AVG TTM
-55.11%
OPERATING MARGIN AVG 3Y
-66.95%
OPERATING MARGIN AVG 5Y
-77.69%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+3.90%
CURRENT VS 3Y AVG
+20.90%
CURRENT VS 5Y AVG
+31.83%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Pulmonx Corporation
Market Cap
$75.18M
Operating Margin
-52.96%
TTM Avg
-55.11%
3Y Avg
-66.95%
5Y Avg
-77.69%
Market Cap
$76.10M
Operating Margin
-1.49%
TTM Avg
-13.59%
3Y Avg
-16.79%
5Y Avg
-16.15%
Market Cap
$76.50M
Operating Margin
-145459.36%
TTM Avg
-145459.36%
3Y Avg
-145459.36%
5Y Avg
-145459.36%
Market Cap
$73.27M
Operating Margin
-273.43%
TTM Avg
-304.38%
3Y Avg
-532.26%
5Y Avg
-2409.22%
Market Cap
$76.84M
Operating Margin
-56.06%
TTM Avg
-77.78%
3Y Avg
-106.34%
5Y Avg
-131.30%
Market Cap
$71.64M
Operating Margin
-33.56%
TTM Avg
-452.40%
3Y Avg
-605.99%
5Y Avg
-446.92%
Market Cap
$77.15M
Operating Margin
-45066.67%
TTM Avg
-46322.29%
3Y Avg
-30673.08%
5Y Avg
-39623.49%
Market Cap
$78.07M
Operating Margin
-132871.32%
TTM Avg
-92244.12%
3Y Avg
-51098.97%
5Y Avg
-37173.74%
Market Cap
$72.83M
Operating Margin
-96.01%
TTM Avg
-72.88%
3Y Avg
-81.45%
5Y Avg
-72.54%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulmonx Corporation (LUNG) | $75.18M | -52.96% | -55.11% | -66.95% | -77.69% |
| SkinHealth Systems Inc. (SKIN)vs › | $76.10M | -1.49% | -13.59% | -16.79% | -16.15% |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $76.50M | -145459.36% | -145459.36% | -145459.36% | -145459.36% |
| Hyperfine, Inc. (HYPR)vs › | $73.27M | -273.43% | -304.38% | -532.26% | -2409.22% |
| Outset Medical, Inc. (OM)vs › | $76.84M | -56.06% | -77.78% | -106.34% | -131.30% |
| Verrica Pharmaceuticals Inc. (VRCA)vs › | $71.64M | -33.56% | -452.40% | -605.99% | -446.92% |
| Sera Prognostics, Inc. (SERA)vs › | $77.15M | -45066.67% | -46322.29% | -30673.08% | -39623.49% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | -132871.32% | -92244.12% | -51098.97% | -37173.74% |
| MindWalk Holdings Corp. (HYFT)vs › | $72.83M | -96.01% | -72.88% | -81.45% | -72.54% |
| Citius Oncology, Inc. (CTOR)vs › | $80.80M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
77.1%
Operating Margin
-53.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -39.80% |
| 2026-03-31 | -62.94% |
| 2025-12-31 | -43.82% |
| 2025-09-30 | -66.94% |
| 2025-06-30 | -62.05% |
| 2025-03-31 | -64.62% |
| 2024-12-31 | -56.46% |
| 2024-09-30 | -69.30% |
| 2024-06-30 | -75.17% |
| 2024-03-31 | -77.10% |
| 2023-12-31 | -72.20% |
| 2023-09-30 | -85.90% |
| 2023-06-30 | -95.61% |
| 2023-03-31 | -112.83% |
| 2022-12-31 | -94.83% |
| 2022-09-30 | -103.18% |
| 2022-06-30 | -103.30% |
| 2022-03-31 | -145.28% |
| 2021-12-31 | -90.21% |
| 2021-09-30 | -73.61% |
| 2021-06-30 | -103.93% |
| 2021-03-31 | -135.16% |
| 2020-12-31 | -95.16% |
| 2020-09-30 | -50.40% |
| 2020-06-30 | -313.80% |
| 2020-03-31 | -70.83% |
| 2019-12-31 | -41.46% |
| 2019-09-30 | -39.69% |
| 2019-06-30 | -65.92% |
| 2019-03-31 | -75.59% |
